Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Algernon and Gromax Capital.....just curious ?
View:
Post by talisman47 on Mar 26, 2021 2:47pm

Algernon and Gromax Capital.....just curious ?

If Gromax has been waiting to be unhalted and they own millions of shares of Algernon that they probably would want to trade or buy......could these be one of the reasons why Algernon kept saying end of the month for their  results ??  Gives Gromax time to get back trading  just before Algernon releases results ?? 

Just seems like coincidental timing......anyone have an opinion??
Comment by Mole101 on Mar 26, 2021 3:37pm
everything is posible , selling shares and exercising Warrants its most likely  Algernon Pharmaceuticals Inc. On November 1, 2019, the Company acquired 5,882,352 units of Algernon Pharmaceuticals Inc. ("Algernon") at $0.085 per unit for a total cost of $500,000 pursuant to a public offering of units of Algernon of approximately $2.07 million  ...more  
Comment by BitHorse on Mar 26, 2021 4:05pm
This post has been removed in accordance with Community Policy
Comment by futuregains on Mar 26, 2021 4:30pm
I am not saying it is good or bad considering the timing of data release and Gromax getting unhalted. It is interesing though. Makes me wonder about next weeks news. All I can say is be ready for a lot of trading. Thoughts anyone?
Comment by BitHorse on Mar 26, 2021 5:01pm
This post has been removed in accordance with Community Policy
Comment by futuregains on Mar 26, 2021 5:46pm
Good point. I checked. There have been very low volume trades the  last couple of days on the US side. None on the Canadian side. To your other point. Yah I agree. King Flipper and the arms length antics (joke) has always been a concern of mine. The CSE is a joke. I didn't find out his involvement until after I bought in. My Bad. Anyway BH I am at the crossroads with you as well. All ...more  
Comment by nodaytrader on Mar 27, 2021 2:50pm
Just speculating but if Ifenprodil is successful, Algernon could sell or license the rights to market it so Algernon would still be developing other drugs and would have a load of cash to distribute to shareholders. Dividends aren’t paid on warrants so major warrant holders would need to convert to shares. just a thought 
Comment by Pandora on Mar 28, 2021 1:29am
A bit more history: VANCOUVER, Dec. 10, 2019 /CNW/ - GrowMax Resources Corp. (TSXV: GRO) ("GrowMax" or the "Company") is pleased to announce that, further to its news releases of August 27, 2019 and September 6, 2019, the Company is in the process of finalizing its filing statement for its proposed change of business from mineral exploration to investment issuer (the " ...more  
Comment by Pandora on Mar 28, 2021 1:51am
VANCOUVER, April 28, 2020 /CNW/ - GrowMax Resources Corp. (TSXV: GRO) ("GrowMax" or the "Company") announced that it has received conditional approval from the TSX Venture Exchange (the "TSXV") of the previously announced proposed change of business from mineral exploration to an investment issuer (the "Proposed COB") under the policies of the TSXV. The ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities